Stenabolic (SR-9009) + Cardarine (GW-501516)

What Does Stenabolic (SR-9009) Cardarine (GW-501516) Combination Do?

Stenabolic (SR-9009) and Cardarine (GW-501516) are investigated in research models for their potential synergistic effects. This combination is being studied for its possible role in metabolism and energy utilization in non-human experimental settings.

Chemical Properties

Stenabolic (SR-9009)

(GW-501516)

Overview of Stenabolic (SR-9009)

Stenabolic (SR-9009) is a synthetic compound that functions as a Rev-Erba agonist in experimental models. Rev-Erba agonist is a nuclear receptor that may regulate circadian rhythm and metabolic processes in preclinical models.

Few preliminary studies have suggested that Stenabolic (SR-9009) may influence energy expenditure and mitochondrial activity.

Overview of Cardarine (GW-501516)

Cardarine (GW-501516) is a synthetic compound classified as a PPARδ receptor agonist. Preclinical research on Cardarine (GW-501516) has shown that it may impact lipid metabolism, glucose utilization, and energy expenditure.

How Does Stenabolic (SR-9009) Cardarine (GW-501516) Work?

Both Stenabolic (SR-9009) and Cardarine (GW-501516) have different working mechanisms as observed in preliminary studies. Here is how these compounds work individually in research subjects

Stenabolic (SR-9009)

Stenabolic (SR-9009) has been shown to work in the following ways in different experimental models.

Interaction with Rev-Erba Receptor in Research Models

In different research settings, SR-9009 has been shown to work by binding to Rev-Erba (NR1D1). Studies suggest that this binding may alter the transcriptional activity of genes that control circadian rhythm, metabolism, and mitochondrial function.

Regulation of Energy and Metabolism in Research Settings

Rev-Erba activation has appeared to influence genes involved in lipid and glucose metabolism in research models as well. In preclinical studies, SR-9009 has been shown to suppress lipid synthesis (lipogenesis) pathways. It has also appeared to enhance oxidative metabolism in skeletal muscle and modify overall energy expenditure in research settings.

Effects on Cellular and Mitochondrial Function in Experimental Models

Researchers have observed that SR-9009 may affect mitochondrial biogenesis and activity. This results in more efficient energy utilization at the cellular level in research settings. These actions may further improve metabolic flexibility in experimental settings. Evidence is limited; no confirmed effects in humans.

Cardarine (GW-501516)

Cardarine (GW-501516) has been shown to work in the following ways in different experimental models.

PPARδ Receptor Activation in Preclinical Models

In different research models, Cardarine has appeared to work by binding to PPARδ. Upon binding, Cardarine may trigger a conformational change that activates the receptor and prepares it to influence DNA transcription in research settings.

Gene Transcription Modulation in Research Settings

These activated PPARδ then linked with retinoid X receptor (RXR) to form a heterodimer. This heterodimer binds to PPAR response elements (PPREs) located in target gene promoters in experimental settings. The result is an upregulation of genes responsible for:

• Fatty acid uptake and transport (e.g., CPT1, FABP).
• Mitochondrial fatty acid oxidation.
• Energy uncoupling and efficiency

Potential Benefits | Stenabolic (SR-9009) Cardarine (GW-501516)

Stenabolic (SR-9009) Cardarine (GW-501516) is still under investigation; however, preliminary studies have shown its following potential benefits in research subjects.

• May enhance endurance capacity in research models.
• Possibly boost metabolic activity in research subjects.
• Might improve energy utilization in preclinical studies.
• Potentially aids lipid regulation in research models.
• May support glucose regulation in research subjects.

Potential Side Effects | Stenabolic (SR-9009) Cardarine (GW-501516)

The following are a few of the side effects observed in research subjects. However, long-term research is required to understand the full safety profile of these compounds.

• May cause fatigue in research subjects.
• Possibly reduce appetite in research models.
• Might alter lipid levels in preclinical studies.
• Potentially affects liver function in research models.
• May disturb sleep patterns in research subjects.

Why is Purerawz a trusted choice?

A lot of people trust our online shop for its authenticity and transparency. We offer third-party tested products to researchers so that they do not have to compromise on the quality. Moreover, we provide secure transaction methods to make sure your privacy remains undisturbed.

FAQs 

What is the half-life of SR-9009 and GW-501516?

SR-9009 might have a short half-life of around 4-6 hours, while GW-501516 may last 16-24 hours in research models. However, more research is needed to understand the accurate half-life of these compounds.

Do SR-9009 and GW-501516 act on the same pathways?

No, SR-9009 interacts with Rev-Erba receptors, while GW-501516 activates PPARδ receptors in research studies.

What is the potential shelf life of SR-9009 and GW-501516?

The stack might remain stable for up to 2 years if stored properly in controlled conditions, as noted in research models.

How quickly do SR-9009 and GW-501516 effects appear in research models?

SR-9009 may show effects within hours due to its short action, while GW-501516 possibly acts over days to weeks.

Disclaimer

This information is for educational purposes only and not medical advice. Products are for research use only. Research must follow IRB or IACUC guidelines. Verify information independently before purchasing. By ordering, you agree to our Terms and Conditions. If you are not 100% satisfied with the product you received, please contact us at support@purerawz.co

ATTENTION: All our products are for LABORATORY AND RESEARCH PURPOSES ONLY, not for veterinary or human use.